Clínica Las Condes Valuation

Is LAS CONDES undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LAS CONDES when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate LAS CONDES's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate LAS CONDES's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LAS CONDES?

Key metric: As LAS CONDES is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for LAS CONDES. This is calculated by dividing LAS CONDES's market cap by their current revenue.
What is LAS CONDES's PS Ratio?
PS Ratio	0.5x
Sales	CL$196.41b
Market Cap	CL$93.09b

LAS CONDES key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.4x
Enterprise Value/EBITDA	10.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does LAS CONDES's PS Ratio compare to its peers?

The above table shows the PS ratio for LAS CONDES vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.6x
INDISA Instituto de Diagnóstico	1x	n/a	CL$219.2b
RPH Ratchaphruek Hospital	2.6x	n/a	฿3.0b
EMC EMC Instytut Medyczny	0.7x	n/a	zł436.9m
MAXIND Max India	6.1x	n/a	₹10.4b
LAS CONDES Clínica Las Condes	0.5x	n/a	CL$93.1b

Price-To-Sales vs Peers: LAS CONDES is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (2.6x).

Price to Sales Ratio vs Industry

How does LAS CONDES's PS Ratio compare vs other companies in the South American Healthcare Industry?

5 Companies	Price / Sales	Estimated Growth	Market Cap

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: LAS CONDES is good value based on its Price-To-Sales Ratio (0.5x) compared to the South American Healthcare industry average (0.8x).

Price to Sales Ratio vs Fair Ratio

What is LAS CONDES's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LAS CONDES PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.5x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate LAS CONDES's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.